Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM Jr, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA Jr.

J Natl Cancer Inst. 2005 Jan 19;97(2):94-102.

PMID:
15657339
2.

SELECT: the selenium and vitamin E cancer prevention trial.

Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

Urol Oncol. 2003 Jan-Feb;21(1):59-65. Review.

PMID:
12684129
3.

Selenium and vitamin E cancer prevention trial.

Klein EA.

Ann N Y Acad Sci. 2004 Dec;1031:234-41. Review.

PMID:
15753149
4.

Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention.

Dunn BK, Ryan A, Ford LG.

Recent Results Cancer Res. 2009;181:183-93. Review.

PMID:
19213568
5.

SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.

Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

J Urol. 2001 Oct;166(4):1311-5.

PMID:
11547064
6.

The selenium and vitamin E cancer prevention trial.

Klein EA, Lippman SM, Thompson IM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

World J Urol. 2003 May;21(1):21-7. Epub 2003 Mar 8. Review.

PMID:
12756490
7.

A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Dunn BK, Richmond ES, Minasian LM, Ryan AM, Ford LG.

Nutr Cancer. 2010;62(7):896-918. doi: 10.1080/01635581.2010.509833. Review.

PMID:
20924966
8.

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr.

JAMA. 2009 Jan 7;301(1):39-51. doi: 10.1001/jama.2008.864. Epub 2008 Dec 9.

9.

Enrollment begins for largest-ever prostate cancer prevention trial.

Miller M.

J Natl Cancer Inst. 2001 Aug 1;93(15):1132. No abstract available.

PMID:
11481383
10.

The future of prostate cancer prevention.

Brawley OW, Barnes S, Parnes H.

Ann N Y Acad Sci. 2001 Dec;952:145-52. Review.

PMID:
11795434
11.

Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.

Pak RW, Lanteri VJ, Scheuch JR, Sawczuk IS.

Integr Cancer Ther. 2002 Dec;1(4):338-44. Review.

PMID:
14664728
12.

Design considerations for efficient prostate cancer chemoprevention trials.

Lee JJ, Lieberman R, Sloan JA, Piantadosi S, Lippman SM.

Urology. 2001 Apr;57(4 Suppl 1):205-12.

PMID:
11295629
13.

Update on chemoprevention of prostate cancer.

Klein EA, Thompson IM.

Curr Opin Urol. 2004 May;14(3):143-9. Review.

PMID:
15069304
14.

Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM Jr, Lucia MS, Kristal AR.

JAMA Oncol. 2015 Jun;1(3):342-9. doi: 10.1001/jamaoncol.2015.0513. Erratum in: JAMA Oncol. 2015 Jun;1(3):322.

15.

Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials.

Tangen CM, Goodman PJ, Crowley JJ, Thompson IM.

J Urol. 2004 Feb;171(2 Pt 2):S64-7.

PMID:
14713757
16.

Prostate cancer prevention: what do we know now and when will we know more?

Thompson IM, Basler J, Hensley D, von Merveldt D, Jenkins CA, Higgins B, Leach R, Troyer D, Pollock B.

Clin Prostate Cancer. 2003 Mar;1(4):215-20. Review.

PMID:
15040879
17.

SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design.

Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

Prostate Cancer Prostatic Dis. 2000 Nov;3(3):145-151.

18.

Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.

Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM Jr, Blanke CD, Klein EA.

JAMA Ophthalmol. 2015 Jan;133(1):17-24. doi: 10.1001/jamaophthalmol.2014.3478.

19.

Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer.

Kim J, Sun P, Lam YW, Troncoso P, Sabichi AL, Babaian RJ, Pisters LL, Pettaway CA, Wood CG, Lippman SM, McDonnell TJ, Lieberman R, Logothetis C, Ho SM.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1697-702.

20.

Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trial.

Chlebowski RT, Menon R, Chaisanguanthum RM, Jackson DM.

Clin Trials. 2010 Dec;7(6):744-8. doi: 10.1177/1740774510383886. Epub 2010 Sep 10.

PMID:
20833684

Supplemental Content

Support Center